Table 1 Demographic characteristics of patients (n = 34)
Patient characteristics | Median (IQR) or number | |
|---|---|---|
Sex | ||
 Male | 6 |  |
 Female | 28 |  |
 Age (years) | 39.0 | (26.3–51.8) |
 Body weight (kg) | 54.7 | (47.2–58.6) |
 Serum albumin (g/dL) | 3.6 | (2.8–3.9) |
 Serum creatinine (mg/dL) | 0.66 | (0.54–0.79) |
 Estimated GFR (mL/min) | 77.4 | (60.3–93.1) |
 Creatinine clearance (mL/min) | 103.6 | (71.1–125.0) |
 Urine protein/creatinine ratio (g/gCre) | 0.25 | (0.14–1.62) |
 Alanine aminotransferase (U/L) | 16.0 | (13.0–20.0) |
 Aspartate aminotransferase (U/L) | 17.0 | (13.3–22.0) |
 Total bilirubin (mg/dL) | 0.56 | (0.43–0.66) |
 C-reactive protein (mg/dL) | 0.06 | (0.04–0.15) |
 Dose of MMF (mg/day) | 1500 | (1500–1688) |
 Dose of MMF/body weight (mg/day/kg) | 27.9 | (24.1–33.2) |
No. of patients receiving concomitant drugs | ||
 Prednisolone | 34 |  |
 Dose of prednisolone (mg) | 10 | (8–30) |
 Tacrolimus | 8 |  |
 Proton pump inhibitor | 22 |  |
 Iron/magnesium oxide | 5 |  |
 NSAIDs | 3 |  |